NCT01199523View on ClinicalTrials.gov

A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females

PHASE1CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Healthy Subjects
Interventions
DRUG

Placebo

oral

DRUG

mirabegron

oral

DRUG

moxifloxacin

oral

Trial Locations (2)

21225

Baltimore

91206

Glendale

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY